cases of cholecystic cancer and 205 cases of benign gall bladder diseases measured by CA 242 and CA19-9 immunoassay were reported.

• 报道了CA-242和CA19-9免疫测定对19例胆囊癌和205例良性胆囊疾病的诊断和鉴别诊断的临床价值。